PHONG DANG: Open Payments
NPI 1346853074 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 22 payments from 12 companies in 2025. Trend: 2023 $1,882 · 2024 $1,313 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $153 |
| Dexcom, Inc. | 1 | $115 |
| Mannkind Corporation | 3 | $111 |
| Astellas Pharma US Inc | 5 | $107 |
| Corcept Therapeutics | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Insulet Corporation | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| MILLICENT US INC | 1 | $15 |
Products named: FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), AFREZZA, Veozah, Korlym, JARDIANCE, Omnipod, RECORLEV.
Industry payments across OK — which companies pay providers there.
